was read the article
array:19 [ "pii" => "X2013251415123120" "issn" => "20132514" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2015;35:157-63" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6681 "formatos" => array:3 [ "EPUB" => 335 "HTML" => 5728 "PDF" => 618 ] ] "itemSiguiente" => array:15 [ "pii" => "X201325141512327X" "issn" => "20132514" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2015;35:164-71" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6562 "formatos" => array:3 [ "EPUB" => 341 "HTML" => 5466 "PDF" => 755 ] ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Acute effect of citrate bath on postdialysis alkalaemia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "164" "paginaFinal" => "171" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efecto agudo del baño con citrato sobre la alcalemia postdiálisis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Patricia De Sequera Ortiz, Marta Albalate Ramón, Rafael Pérez-García, Elena Corchete Prats, Patricia Arribas Cobo, Roberto Alcázar Arroyo, Maira Ortega Díaz, Marta Puerta Carretero" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Patricia" "apellidos" => "De Sequera Ortiz" ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Albalate Ramón" ] 2 => array:2 [ "nombre" => "Rafael" "apellidos" => "Pérez-García" ] 3 => array:2 [ "nombre" => "Elena" "apellidos" => "Corchete Prats" ] 4 => array:2 [ "nombre" => "Patricia" "apellidos" => "Arribas Cobo" ] 5 => array:2 [ "nombre" => "Roberto" "apellidos" => "Alcázar Arroyo" ] 6 => array:2 [ "nombre" => "Maira" "apellidos" => "Ortega Díaz" ] 7 => array:2 [ "nombre" => "Marta" "apellidos" => "Puerta Carretero" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141512327X?idApp=UINPBA000064" "url" => "/20132514/0000003500000002/v0_201504231604/X201325141512327X/v0_201504231605/en/main.assets" ] "itemAnterior" => array:15 [ "pii" => "X2013251415123112" "issn" => "20132514" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2015;35:150-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5126 "formatos" => array:3 [ "EPUB" => 312 "HTML" => 4261 "PDF" => 553 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "The effect of some medications given to CKD patients on vitamin D levels" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "150" "paginaFinal" => "156" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efectos de algunos fármacos administrados a los pacientes de ERC sobre los niveles de vitamina D" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "498v35n02-90412311fig4.jpg" "Alto" => 912 "Ancho" => 1012 "Tamanyo" => 66057 ] ] "descripcion" => array:1 [ "en" => " Relationship between therapies and baseline serum 25¿OH¿D3 levels. Patients were divided in three groups according with the concomitant therapies, and there were significant statistical differences between groups (p <0 001 patients who were not receiving renin angiotensin system ras inhibitors or allopurinol n="30)" presented lower 25 8209 oh d3 d levels than those and plus p <0 001 highest 25 8209 oh d3 levels 11 7 3 p="0.005)" were found in patients receiving ras inhibitors plus allopurinol without statins lowest 5 1 82 who only</0> </0>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Claudia Yuste, Borja Quiroga, Soledad García de Vinuesa, Maria Angeles Goicoechea, Daniel Barraca, Ursula Verdalles, Jose Luño" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Claudia" "apellidos" => "Yuste" ] 1 => array:2 [ "nombre" => "Borja" "apellidos" => "Quiroga" ] 2 => array:2 [ "nombre" => "Soledad" "apellidos" => "García de Vinuesa" ] 3 => array:2 [ "nombre" => "Maria Angeles" "apellidos" => "Goicoechea" ] 4 => array:2 [ "nombre" => "Daniel" "apellidos" => "Barraca" ] 5 => array:2 [ "nombre" => "Ursula" "apellidos" => "Verdalles" ] 6 => array:2 [ "nombre" => "Jose" "apellidos" => "Luño" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251415123112?idApp=UINPBA000064" "url" => "/20132514/0000003500000002/v0_201504231604/X2013251415123112/v0_201504231605/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "titulo" => "Valvular calcifications at the start of dialysis predict the onset of cardiovascular events in the course of follow-up" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "157" "paginaFinal" => "163" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Carmen Sánchez-Perales, Eduardo Vázquez Ruiz de Castroviejo, Mª José García-Cortés, Mª del Mar Biechy, Jose Manuel Gil-Cunquero, Josefa Borrego-Hinojosa, Pilar Pérez del Barrio, Francisco Borrego-Utiel, Antonio Liébana" "autores" => array:9 [ 0 => array:3 [ "nombre" => "Carmen" "apellidos" => "Sánchez-Perales" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Eduardo" "apellidos" => "Vázquez Ruiz de Castroviejo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "Mª José" "apellidos" => "García-Cortés" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "nombre" => "Mª del Mar" "apellidos" => "Biechy" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "nombre" => "Jose Manuel" "apellidos" => "Gil-Cunquero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 5 => array:3 [ "nombre" => "Josefa" "apellidos" => "Borrego-Hinojosa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 6 => array:3 [ "nombre" => "Pilar" "apellidos" => "Pérez del Barrio" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 7 => array:3 [ "nombre" => "Francisco" "apellidos" => "Borrego-Utiel" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 8 => array:3 [ "nombre" => "Antonio" "apellidos" => "Liébana" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Nephrology, Complejo Hospitalario de Jaén [Hospital Complex of Jaén], Jaén " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Cardiology, Complejo Hospitalario de Jaén, Jaén" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Las calcificaciones valvulares al inicio de diálisis predicen la aparición de eventos cardiovasculares en la evolución" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "498v35n02-90412312fig5.jpg" "Alto" => 904 "Ancho" => 2000 "Tamanyo" => 111002 ] ] "descripcion" => array:1 [ "en" => " Event-free survival (MI, stroke and/or death from cardiovascular causes); Kaplan-Meier Curves A: all patients; B: patients with no diagnosis of coronary artery disease, stroke or AF at the start of dialysis; VC: valvular calcification" ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Introduction </span></p><p class="elsevierStylePara"> The presence of cardiac valvular calcifications (VC) in chronic kidney disease (CKD) is considered a frequent fact. Population studies have confirmed an association between CKD and mitral or aortic VC from initial stages of decreased glomerular filtration1,2. Nevertheless, most publications derive from studies of prevalent peritoneal dialysis and haemodialysis patients, in which the prevalence of VC is greater than 30% of patients3,4,5. In these studies, VC correlates with the time on replacement therapy, inflammation, malnutrition and atherosclerotic heart disease6,7,8,9,10. VC has been a predictor for mortality from cardiovascular causes and from any other cause3 in some studies, although not in all of them11.</p><p class="elsevierStylePara"> VC and atherosclerosis are frequently observed in a same patient on dialysis, and the association between them has been demonstrated<span class="elsevierStyleSup">7,12</span>. Based on this association, VC has been considered one of the manifestations of atherosclerosis<span class="elsevierStyleSup">7,13</span>. However, all patients with VC do not have atherosclerosis. This suggests that, although both processes share pathogenic mechanisms, their pathogenesis and possibly the risk they involve are not identical<span class="elsevierStyleSup">14</span>.</p><p class="elsevierStylePara"> There are few studies about VC in patients with advanced stages of CKD at the onset of replacement therapy<span class="elsevierStyleSup">15,16</span>.</p><p class="elsevierStylePara"> The purpose of this study was to analyse the presence of VC in patients who started dialysis for the first time and its relationship with the occurrence of events and cardiovascular mortality during follow-up.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Methods </span></p><p class="elsevierStylePara"> We included patients diagnosed with stage 5 CKD, who started haemodialysis or peritoneal dialysis for the first time between November 2003 and September 2007 in our hospital centre. Patients who started treatment in another centre or had undergone prior renal transplantation were excluded. The observational period ranged from the first day of dialysis to termination due to transplantation, death, patient transfer outside our health area of influence, or the end of the study 31 December 2012.</p><p class="elsevierStylePara"> In the first month of dialysis, the following variables were assessed and included for analysis: demographic characteristics; anthropometric measurements; pulse pressure; history of hypertension and/or antihypertensive treatment (HTN); diabetes with indication of drug treatment at any time of follow-up; active smoking habit or cessation in the last 10 years; coronary artery disease documented by a history of myocardial infarction (MI) or compatible coronary angiographic test; ischaemic or haemorrhagic stroke, documented by a neurologist and/or imaging test report; atrial fibrillation (AF) in any of its forms documented in a prior medical record or by an ECG finding; and, analytical variables, such as haemoglobin, mineral metabolism (calcium, phosphorous, PTH), urea, creatinine, troponin I, albumin, C-reactive protein (CRP), cholesterol and fractions, triglycerides and glycosylated haemoglobin.</p><p class="elsevierStylePara"> VC was studied with colour Doppler echocardiography by a single observer. It was defined as increased echo-refringence with a thickness > 1 mm at the level of the mitral or aortic annulus or leaf let. Three grades were established according to the calcification area: mild, when there were only small, isolated areas; moderate, when there were multiple areas; and severe, when calcification was extensive and diffuse. It was analysed whether the calcification was limited to only one valve, mitral or aortic, or involved both.</p><p class="elsevierStylePara"> The endpoint of our study was the occurrence of one or several of the following events in the course of follow-up: MI, stroke or death from cardiovascular causes (defined as death due to heart failure), pulmonary thromboembolism, sudden death, mesenteric ischaemia or peripheral arterial ischaemia.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Statistical Analysis </span></span></p><p class="elsevierStylePara"> The Student’s <span class="elsevierStyleItalic">t</span>-test or the nonparametric Mann-Whitney test was used for the comparison of means. For the comparison of qualitative variables, the Pearson’s Chi-square test was used. For the analysis of the association between VC and the risk factors that were present at the start of treatment, a logistic regression multivariate analysis was performed, and the odds ratio (OR) and 95% confidence interval were obtained. The predictive power of variables for the occurrence of the endpoint of our study was analysed through a Cox proportional-hazard regression analysis. The prognostic variable was the occurrence of the endpoint defined in the Methods section. Predictive variables were the presence of VC, and other variables with significant association in the univariate analysis or of special significance. The hazard ratio (HR) and 95% confidence interval were obtained.</p><p class="elsevierStylePara"> Event-free survival was analysed with the Kaplan-Meier method, and the Mantel-Haenszel test (log-rank) was used to compare survival curves. For hypothesis contrast tests, a value of <span class="elsevierStyleItalic">p</span> < 0.05 was considered statistically significant. The analyses were carried out with the statistical package SPSS 15.0 for Windows.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Results </span></span></p><p class="elsevierStylePara"> Following the exclusion criteria, 48 patients were not included; another 29 patients were not included since they could not participate in the entire initial study. The total number of enrolled patients was 256. Mean age was 65.1 ± 15.9 years, median age was 69.9, and 146 patients (57%) were male. Nephropathies induced by renal failure included the following: glomerulonephritis 17.2%; interstitial nephropathies 15.2%; nephrosclerosis 15.6%; polycystic kidney disease 6.3%; other familial diseases 1.2%; systemic diseases 5.1%; diabetes 18.4%; unidentified diseases 18.8%; other 2.3%. Diabetes caused nephropathy or was a concomitant disease in 73 (28.5%) patients.</p><p class="elsevierStylePara"> They study included 213 (83%) patients receiving haemo-dialysis and 43 (17%) patients in peritoneal dialysis, with a mean age of 66.8 ± 14.8 and 56.5 ± 18.5 years, respectively (<span class="elsevierStyleItalic">p</span> = 0.004). Patients were monitored for 42.1 ± 30 months (range: 0.23–109.4), with a follow-up of 898.1 patient-years.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Prevalence of Valvular Calcification </span></span></p><p class="elsevierStylePara"> At the beginning of the dialysis programme, valvular calcification (VC) was present in 128 patients, which accounts for a prevalence of 50%. The grades were: 90 mild (35.1%); 30 moderate (11.7%); and 8 severe (3.1%). Calcification was present in the mitral valve in 39 (15.2%) patients, the aortic valve in 20 (7.8%), and in both valves in 69 (27%) patients.</p><p class="elsevierStylePara"> Those patients who had valvular calcification were an average of 18 years older and were mostly women, diabetic patients, and had a history of cardiovascular events and diagnosis of atrial fibrillation. A higher proportion of patients included in the haemodialysis programme had valvular calcification. Creatinine, albumin and phosphorous levels were lower, while pulse pressure and body mass index were higher (Table 1). They also had greater left ventricular mass and left atrial dimension and greater diastolic dysfunction (Table 2).</p><p class="elsevierStylePara"><img alt="Table 1 Characteristics of patients with VC at the start of dialysis" src="498v35n02-90412312fig1.jpg"></img></p><p class="elsevierStylePara"><img alt="Table 2 Echocardiographic parameters" src="498v35n02-90412312fig2.jpg"></img></p><p class="elsevierStylePara"> Frequency of HT and smoking habit, calcium levels, iPTH, anaemia or dyslipidemia, and systolic function assessed by echocardiography were not different from those observed in patients who did not have valvular calcification.</p><p class="elsevierStylePara"> In the multivariate logistic regression analysis, we included factors with statistical significance in the univariate analysis and other factors of potential involvement in the valvular calcification process: total cholesterol, HDL and LDL fractions, triglycerides, CRP, and left ventricular ejection fraction (LVEF). In this analysis, the factors independently related to the presence of VC were older age and lower albumin level (Table 3).</p><p class="elsevierStylePara"><img alt="Table 3 Factors associated with the presence of VC at the start of dialysis. Logistic Regression Analysis" src="498v35n02-90412312fig3.jpg"></img></p><p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Occurrence of endpoint </span></span></p><p class="elsevierStylePara"> During follow-up, 68 patients presented endpoint events of the study: MI, stroke, and/or death from cardiovascular causes. The distribution was as follows:</p><p class="elsevierStylePara"> • Patients who died from cardiovascular causes: 50. Causes included: 8 MI; 7 stroke, of which 5 were haemorrhagic and 2 ischaemic, and 1 patient also had MI; 13 sudden death; 9 heart failure, cardiogenic shock or malignant arrhythmia; 8 mesenteric ischaemia; 2 pulmonary thromboembolism; 3 arterial ischaemia/lower limb amputation.</p><p class="elsevierStylePara"> • Patients who had cardiovascular events: 18, of which 10 were MI, 7 were strokes, and 1 patient had MI and stroke. Twelve of these patients died in the follow-up due to non-cardiovascular causes, one received a renal transplant, and five were alive at the end of the study.</p><p class="elsevierStylePara"> The 68 patients who experienced an endpoint event were older than the 188 patients who did not. Most were diabetic patients and patients with a history of AF, MI and/or stroke. In the echocardiographic test, they showed greater left ventricular mass and left atrial dilation with less left ventricular ejection fraction. Valvular calcification was more frequent in these patients (Table 4).</p><p class="elsevierStylePara"><img alt="Table 4 Patients who had the event (MI, stroke and/or death from cardiovascular causes)" src="498v35n02-90412312fig4.jpg"></img></p><p class="elsevierStylePara"> In the Kaplan-Meier analysis, the event-free survival was shorter in patients with valvular calcification. This difference was maintained when the analysis was performed in the 192 (75%) patients with no prior diagnosis of coronary artery disease, stroke or AF (Figure 1).</p><p class="elsevierStylePara"><img alt="Figure 1 Event-free survival (MI, stroke and/or death from cardiovascular causes); Kaplan-Meier Curves A: all patients; B: patients with no diagnosis of coronary artery disease, stroke or AF at the start of dialysis; VC: valvular calcification" src="498v35n02-90412312fig5.jpg"></img></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Figure 1 – Event-free survival (MI, stroke and/or death from cardiovascular causes); Kaplan-Meier Curves A: all patients; B: patients with no diagnosis of coronary artery disease, stroke or AF at the start of dialysis; VC: valvular calcification</span></p><p class="elsevierStylePara"> The occurrence of endpoint events increased according to the VC grade. In the absence of calcification, 13.2% of patients presented an event, 37% with mild or moderate grade and 75% of patients with severe grade (Figure 2).</p><p class="elsevierStylePara"><img alt="Figure 2 Event occurrence (MI, stroke and/or death from cardiovascular causes) by VC grade. VC: absent vs. mild-moderate, p = 0.000; absent vs. severe, p = 0.000; mild-moderate vs. severe, p = 0.036" src="498v35n02-90412312fig6.jpg"></img></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Figure 2 – Event occurrence (MI, stroke and/or death from cardiovascular causes) by VC grade. VC: absent vs. mild-moderate, </span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">p</span></span><span class="elsevierStyleBold"> = 0.000; absent vs. severe, </span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">p</span></span><span class="elsevierStyleBold"> = 0.000; mild-moderate vs. severe, </span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">p</span></span><span class="elsevierStyleBold"> = 0.036</span></p><p class="elsevierStylePara"> In the Cox regression analysis, we included variables with statistical significance in the univariate analysis and others that were potentially associated with cardiovascular morbidity-mortality, such as sex, haemoglobin, phosphorous, CRP and dialysis technique. The factors independently associated with the occurrence of the endpoint of the study were the presence of VC at the start of dialysis, older age, and prior diagnoses of AF, coronary artery disease, and/or stroke (Table 5).</p><p class="elsevierStylePara"><img alt="Table 5 Predictive factors for event occurrence (MI, stroke and/or death from cardiovascular causes). Cox Regression Analysis" src="498v35n02-90412312fig7.jpg"></img></p><p class="elsevierStylePara"> To assess whether VC severity increased the risk for endpoint events, the same analysis was performed for the calcification grades. For mild-moderate grade VC, the results were the following: HR 1.780 (95% CI 0.953–3.346, <span class="elsevierStyleItalic">p</span> = 0.07). Results for severe grade VC were: HR 4.517 (95% CI: 1.827– 11.809, <span class="elsevierStyleItalic">p</span> = 0.02).</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Discussion </span></p><p class="elsevierStylePara"> The results of this study show that there is a high prevalence of VC in patients who start dialysis and that the presence of VC is associated with the occurrence of cardiovascular events and mortality in the course of follow-up. In the last decade, the scientific literature has shown that the frequency of VC (aortic, mitral, or both) in CKD is high. In the Framingham study, CKD (11% of patients with glomerular filtration rate < 40 mL/min) increased the risk of mitral valve calcification by 60%, although not aortic calcification<span class="elsevierStyleSup">1</span>. Another study did not find an association between glomerular filtration rate < 60 mL/min and aortic valve calcification, but it did find an association with mitral valve calcification in diabetic patients only<span class="elsevierStyleSup">2</span>. Most of the information about VC is from prevalent dialysis population studies, with a prevalence ranging from 30 to 70% of patients on both peritoneal dialysis<span class="elsevierStyleSup">3,2</span> and haemodialysis<span class="elsevierStyleSup">4,5,11</span>. However, studies of patients who initiate dialysis are less frequent. A recent published study of incident dialysis patients in Japan showed a VC prevalence of 57.7%, for an age slightly younger than that of our study<span class="elsevierStyleSup">15</span>. In another publication, the prevalence of VC at the start of dialysis was 35.6% for patients 15 years younger than our patients<span class="elsevierStyleSup">16</span>.</p><p class="elsevierStylePara"> In our study, older age and lower levels of albumin (an inflammatory and malnutrition marker) were independently associated with the presence of VC. Age is an important factor associated with VC<span class="elsevierStyleSup">3,6</span>, along with inflammatory markers. In prevalent dialysis patients, an association was demonstrated between VC and inflammatory markers, such as β2 microglobulin, cytokines, CRP and others like fetuin A<span class="elsevierStyleSup">5,15,9,8</span>.</p><p class="elsevierStylePara"> In the baseline assessment, patients with VC had a higher incidence of history of cardiovascular events, AF and diabetes, along with higher blood pressure and pulse pressure as well as structural alterations such as left ventricular hypertrophy and greater diastolic dysfunction. In studies of patients with VC on dialysis, cardiovascular disease and structural cardiac alterations have not always been assessed. In prevalent patients, VC has been associated with coronary artery disease<span class="elsevierStyleSup">10</span>, a history of cardiovascular events and left ventricular hypertrophy<span class="elsevierStyleSup">11</span>, and carotid intima-media thickness<span class="elsevierStyleSup">13</span>. In the Japanese study of events during dialysis, cardiovascular events and structural cardiac alterations were not analysed<span class="elsevierStyleSup">15</span>. In another study, patients with prior coronary artery events were excluded<span class="elsevierStyleSup">16</span>.</p><p class="elsevierStylePara"> VC was not associated with alterations in bone-mineral metabolism, which is similar to other studies of incident dialysis patients<span class="elsevierStyleSup">15,6</span>; some studies of prevalent patients have shown an association between VC and some biochemical alterations in calcium/phosphorous metabolism<span class="elsevierStyleSup">17,18</span>. A possible explanation is the better phosphorous control in incident patients with residual renal function, which does not exclude the involvement of bone-mineral metabolism alterations in the genesis of VC. The pathogenesis of VC and vascular calcification is not clear, although they share mechanisms; in patients on dialysis, a correlation between VC and vascular calcification has been shown<span class="elsevierStyleSup">19</span>. CKD involves alterations in calcium/phosphorous metabolism and bone remodelling, inflammation and imbalance between inducers and inhibitors of calcification. The final result is the phenotypical change of cells in valvular and vascular structures to osteoblasts<span class="elsevierStyleSup">20,21</span>.</p><p class="elsevierStylePara"> Both in experimental studies<span class="elsevierStyleSup">22</span> and clinical studies23, an inverse correlation has been shown between vascular and valvular calcification with the loss of bone mineralization, and, in patients on dialysis, it has been shown that the presence of VC is associated with a greater progression of coronary calcification, measured by multi-slice CT<span class="elsevierStyleSup">16</span>. In the ADVANCE study, patients treated with the calcimimetic cinacalcet showed less increase in the progression of aortic valve calcification, which indicates the involvement of mineral metabolism disorders in VC<span class="elsevierStyleSup">24</span>.</p><p class="elsevierStylePara"> Another matter is the importance of VC as a predictive factor for cardiovascular risk in patients on dialysis. In studies of prevalent haemodialysis patients, VC was a predictor variable for all-cause mortality<span class="elsevierStyleSup">4</span>. In prevalent peritoneal dialysis patients, it was a predictor for cardiovascular mortality and mortality from any cause; this is similar to the risk posed by the history of atherosclerotic events, which establishes it as a cardiovascular disease marker<span class="elsevierStyleSup">3</span>. In other studies, VC was not a predictor of mortality in the multivariate analysis adjusted for age and inflammatory markers<span class="elsevierStyleSup">16</span> or adjusted for prior cardiovascular events<span class="elsevierStyleSup">11</span>. A study of asymptomatic prevalent dialysis patients (69% haemodialysis) at high risk for cardiovascular disease, segmental alterations in myocardial contractility and LVEF < 40% demonstrated an association between VC and the presence of inducible myocardial ischaemia; this suggests that VC may be a marker for silent myocardial ischaemia risk in this population<span class="elsevierStyleSup">25</span>.</p><p class="elsevierStylePara"> In this study, VC was a predictor variable for the occurrence of MI, stroke and/or death from cardiovascular causes. There were more severe VC events than mild-moderate events (Figure 2). In the multivariate analysis adjusted for all the included variables, the mild-moderate grade was observed at the limit of statistical significance as a predictor variable for endpoint events.</p><p class="elsevierStylePara"> The availability of simple tools is important to assess cardiovascular risk. In studies conducted in our institution, the history of cardiovascular events recorded in medical records, data from exploratory tests and electrocardiograms were useful to predict cardiovascular risk in our population on dialysis<span class="elsevierStyleSup">26,27,28,29</span>. Echocardiography is a safe, low-cost, widely available technique and a simple tool that adds value to the results of this study.</p><p class="elsevierStylePara"> In summary, at the start of a dialysis programme, a high proportion of patients have VC. This fact doubles the risk of MI, stroke and/or death from cardiovascular causes during the course of dialysis. The magnitude of this risk is similar to that of cardiovascular disease or the presence of AF before the start of dialysis.</p><hr></hr><p class="elsevierStylePara"> Sent for Review: 22 June 2014 <br></br> Accepted on: 21 Oct. 2014</p><p class="elsevierStylePara"><a href="http://dx.doi.org/10.3265/Nefrologia.pre2014.Oct.12640" class="elsevierStyleCrossRefs">http://dx.doi.org/10.3265/Nefrologia.pre2014.Oct.12640</a></p><p class="elsevierStylePara"> * <span class="elsevierStyleItalic">Corresponding author</span>.<br></br> Carmen Sánchez-Perales, <br></br> Nephrology, Complejo Hospitalario de Jaén, <br></br> Navas de Tolosa 4 y 6.P1, 6º D, 23003, Jaén <br></br><span class="elsevierStyleItalic">E-mail:</span><a href="mailto:mcsanchezp@senefro.org" class="elsevierStyleCrossRefs">mcsanchezp@senefro.org</a></p>" "pdfFichero" => "498v35n02a90412312pdf001.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec503488" "palabras" => array:3 [ 0 => "Calcificación valvular" 1 => "Diálisis" 2 => "Factores de riesgo cardiovascular" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec503487" "palabras" => array:3 [ 0 => "Valvular calcification" 1 => "Dialysis" 2 => "Cardiovascular risk factors" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<p class="elsevierStylePara"> La calcificación valvular (CV) en la enfermedad renal crónica es frecuente, aunque la mayor parte de la información procede de pacientes prevalentes en diálisis. Son pocos los estudios que analicen la CV en los pacientes que inician diálisis.</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Objetivo:</span> Analizar la presencia de CV al inicio de diálisis y su relación con eventos y/o muerte cardiovascular en la evolución.</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Métodos:</span> Incluimos en el estudio los pacientes incidentes en diálisis entre nov/03 y sept/07. En el 1º mes de tratamiento analizamos la presencia de CV mediante Ecocardiograma-doppler, junto a factores demográficos y de riesgo cardiovascular, enfermedad coronaria, accidente cerebrovascular (ACV), fibrilación auricular (FA) y parámetros de electro y ecocardiográficos dimensionales y funcionales cardiacos. Los valores bioquímicos analizados fueron: hemoglobina, metabolismo calcio/fósforo/iPTH, colesterol y fracciones, triglicéridos, troponina I, albúmina, PCR y hemoglobina glicosilada. Analizamos la asociación de la CV con la presentación de infarto de miocardio (IAM), ACV y/o muerte cardiovascular hasta el trasplante, muerte, o fin del estudio (dic/2012).</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Resultados:</span> De 256 pacientes incluidos (83% hemodiálisis, 17% diálisis peritoneal), 128 (50%) presentaban CV (mitral: 39, aórtica: 20, ambas: 69). En el análisis multivariante la CV se asoció a mayor edad (OR: 1,110; IC 95%: 1,073-1,148; p = 0,000) y menor albúmina (OR: 0,29; IC 95%: 0,14-0,61; p = 0,001). En un seguimiento de 42,1 ± 30,2 meses (898,1 pacientesaño), 68 pacientes presentaron IAM, ACV y/o murieron por causa cardiovascular. En el análisis de regresión de Cox, la mayor edad (HR: 1,028; IC 95%: 1,002-1,055; p = 0,037), la enfermedad coronaria y/o ACV (HR: 1,979; IC95%: 1,111-3,527; p = 0,021), la FA (HR: 2,474; IC 95%: 1,331-4,602; p = 0,004) y la presencia de CV antes de entrar en diálisis (HR: 1,996; IC 95%: 1,077-3,700; p = 0,028), fueron predictores independientes de la presentación de los eventos analizados.</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Conclusiones:</span> La prevalencia de CV en el momento de iniciar diálisis es alta y su presencia predice la presentación de eventos y/o muerte cardiovascular en la evolución.</p>" ] "en" => array:1 [ "resumen" => "<p class="elsevierStylePara"> Valvular calcification (VC) in chronic kidney disease is frequent, although most information derives from prevalent dialysis patients. There are few studies that analyse VC in patients who start dialysis.</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Objective:</span> To analyse the presence of VC at the start of dialysis and its relationship with events and/or death from cardiovascular causes in the course of follow-up.</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Methods: </span>In the study, we included patients who started dialysis between November 2003 and September 2007. In the first month of treatment, we assessed the presence of VC by Doppler echocardiography, along with demographic factors and risk factors for cardiovascular disease, coronary artery disease, stroke, atrial fibrillation (AF), and cardiac dimensional and functional electrocardiographic and echocardiographic parameters. The biochemistry values assessed were: haemoglobin, calcium/phosphorous/iPTH metabolism, cholesterol and fractions, triglycerides, troponin I, albumin, CRP and glycosylated haemoglobin. We analysed the association between VC and the presence of myocardial infarction (MI), stroke and/or death from cardiovascular causes up to transplantation, death or the end of the study (December 2012).</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Results: </span>Of 256 enrolled patients (83% haemodialysis, 17% peritoneal dialysis), 128 (50%) had VC (mitral: 39, aortic: 20, both: 69). In the multivariate analysis, VC was associated with older age (OR: 1.110; 95% CI: 1.073–1.148; <span class="elsevierStyleItalic">p</span> = 0.000) and lower albumin levels (OR: 0.29; 95% CI: 0.14–0.61; <span class="elsevierStyleItalic">p</span> = 0.001). In a follow-up lasting 42.1 ± 30.2 months (898.1 patient-years), 68 patients suffered MI, stroke and/or died from cardiovascular causes. In the Cox regression analysis, older age (HR: 1.028; 95% CI: 1.002–1.055; <span class="elsevierStyleItalic">p</span> = 0.037), coronary artery disease and/or stroke (HR: 1.979; 95% CI: 1.111–3.527; <span class="elsevierStyleItalic">p</span> = 0.021), AF (HR: 2.474; 95% CI: 1.331–4.602; <span class="elsevierStyleItalic">p</span> = 0.004), and the presence of VC at the start of dialysis (HR: 1.996; 95% CI: 1.077–3.700; <span class="elsevierStyleItalic">p</span> = 0.028) were the predictor variables for the occurrence of the analysed events.</p> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Conclusions:</span> The prevalence of VC at the start of dialysis is high and its presence predicts the occurrence of events and/or cardiovascular death in the course of follow-up.</p>" ] ] "multimedia" => array:7 [ 0 => array:8 [ "identificador" => "tbl1" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "498v35n02-90412312fig1.jpg" "imagenAlto" => 1083 "imagenAncho" => 1033 "imagenTamanyo" => 192238 ] ] ] ] ] "descripcion" => array:1 [ "en" => " Characteristics of patients with VC at the start of dialysis" ] ] 1 => array:8 [ "identificador" => "tbl2" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "498v35n02-90412312fig2.jpg" "imagenAlto" => 583 "imagenAncho" => 1029 "imagenTamanyo" => 95708 ] ] ] ] ] "descripcion" => array:1 [ "en" => " Echocardiographic parameters" ] ] 2 => array:8 [ "identificador" => "tbl3" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "498v35n02-90412312fig3.jpg" "imagenAlto" => 358 "imagenAncho" => 1041 "imagenTamanyo" => 64614 ] ] ] ] ] "descripcion" => array:1 [ "en" => " Factors associated with the presence of VC at the start of dialysis. Logistic Regression Analysis" ] ] 3 => array:8 [ "identificador" => "tbl4" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "498v35n02-90412312fig4.jpg" "imagenAlto" => 912 "imagenAncho" => 1041 "imagenTamanyo" => 153084 ] ] ] ] ] "descripcion" => array:1 [ "en" => " Patients who had the event (MI, stroke and/or death from cardiovascular causes)" ] ] 4 => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "498v35n02-90412312fig5.jpg" "Alto" => 904 "Ancho" => 2000 "Tamanyo" => 111002 ] ] "descripcion" => array:1 [ "en" => " Event-free survival (MI, stroke and/or death from cardiovascular causes); Kaplan-Meier Curves A: all patients; B: patients with no diagnosis of coronary artery disease, stroke or AF at the start of dialysis; VC: valvular calcification" ] ] 5 => array:8 [ "identificador" => "fig2" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "498v35n02-90412312fig6.jpg" "Alto" => 770 "Ancho" => 1025 "Tamanyo" => 65016 ] ] "descripcion" => array:1 [ "en" => " Event occurrence (MI, stroke and/or death from cardiovascular causes) by VC grade. VC: absent vs. mild-moderate, p = 0.000; absent vs. severe, p = 0.000; mild-moderate vs. severe, p = 0.036" ] ] 6 => array:8 [ "identificador" => "tbl5" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "498v35n02-90412312fig7.jpg" "imagenAlto" => 525 "imagenAncho" => 1033 "imagenTamanyo" => 88172 ] ] ] ] ] "descripcion" => array:1 [ "en" => " Predictive factors for event occurrence (MI, stroke and/or death from cardiovascular causes). Cox Regression Analysis" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:29 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol. 2006;17:521-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16382018" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Fox CS" 1 => "Larson MG" 2 => "Vasan RS" 3 => "Guo CY" 4 => "Parise H" 5 => "Levy D" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2005060627" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol. " "fecha" => "2006" "volumen" => "17" "paginaInicial" => "521" "paginaFinal" => "7" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16382018" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2007;50:412-20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17720520" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Ix JH" 1 => "Shlipak MG" 2 => "Katz R" 3 => "Budoff MJ" 4 => "Shavelle DM" 5 => "Probstfield JL" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2007.05.020" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis. " "fecha" => "2007" "volumen" => "50" "paginaInicial" => "412" "paginaFinal" => "20" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17720520" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14:159-68. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12506148" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Wang AY" 1 => "Wang M" 2 => "Woo J" 3 => "Lam CW" 4 => "Li PK" 5 => "Lui SF" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol. " "fecha" => "2003" "volumen" => "14" "paginaInicial" => "159" "paginaFinal" => "68" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12506148" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "All-cause mortality in hemodialysis patients with heart valve calcification. Clin J Am Soc Nephrol. 2011;6:1990-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21700824" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "All-cause mortality in hemodialysis patients with heart valve calcification." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Raggi P" 1 => "Bellasi A" 2 => "Gamboa C" 3 => "Ferramosca E" 4 => "Ratti C" 5 => "Block GA" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.01140211" "Revista" => array:6 [ "tituloSerie" => "Clin J Am Soc Nephrol. " "fecha" => "2011" "volumen" => "6" "paginaInicial" => "1990" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21700824" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Differences in associated factors between aortic and mitral valve calcification in hemodialysis. Hypertens Res. 2010;33:622-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20379193" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Differences in associated factors between aortic and mitral valve calcification in hemodialysis." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Ikee R" 1 => "Honda K" 2 => "Ishioka K" 3 => "Oka M" 4 => "Maesato K" 5 => "Moriya H" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/hr.2010.44" "Revista" => array:6 [ "tituloSerie" => "Hypertens Res. " "fecha" => "2010" "volumen" => "33" "paginaInicial" => "622" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20379193" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39:695-701. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11849871" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cardiac calcification in adult hemodialysis patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Raggi P" 1 => "Boulay A" 2 => "Chasan-Taber S" 3 => "Amin N" 4 => "Dillon M" 5 => "Burke SK" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. " "fecha" => "2002" "volumen" => "39" "paginaInicial" => "695" "paginaFinal" => "701" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis. 2009;18:429-38. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19852148" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Valvular calcification and its relationship to atherosclerosis in chronic kidney disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Leskinen Y" 1 => "Paana T" 2 => "Saha H" 3 => "Groundstroem K" 4 => "Lehtimäki T" 5 => "Kilpinen S" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Heart Valve Dis. " "fecha" => "2009" "volumen" => "18" "paginaInicial" => "429" "paginaFinal" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19852148" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20:1676-85. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15899935" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Wang AY" 1 => "Woo J" 2 => "Lam CW" 3 => "Wang M" 4 => "Chan IH" 5 => "Gao P" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfh891" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant. " "fecha" => "2005" "volumen" => "20" "paginaInicial" => "1676" "paginaFinal" => "85" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15899935" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study. Am J Nephrol. 2008; 28:647-53. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18292652" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Wang AY" 1 => "Lam CW" 2 => "Wang M" 3 => "Chan IH" 4 => "Yu CM" 5 => "Lui SF" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000117817" "Revista" => array:6 [ "tituloSerie" => "Am J Nephrol. " "fecha" => "2008" "volumen" => "28" "paginaInicial" => "647" "paginaFinal" => "53" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18292652" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Cardiol. 2005;95:742-3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15757600" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Varma R" 1 => "Aronow WS" 2 => "McClung JA" 3 => "Garrick R" 4 => "Vistainer PF" 5 => "Weiss MB" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2004.11.025" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol. " "fecha" => "2005" "volumen" => "95" "paginaInicial" => "742" "paginaFinal" => "3" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15757600" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis. 2004;43:479-84. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14981606" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Panuccio V" 1 => "Tripepi R" 2 => "Tripepi G" 3 => "Mallamaci F" 4 => "Benedetto FA" 5 => "Cataliotti A" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis. " "fecha" => "2004" "volumen" => "43" "paginaInicial" => "479" "paginaFinal" => "84" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14981606" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Close association of vascular and valvular calcification and prognosis of patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial. 2008;24:60-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18986003" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Close association of vascular and valvular calcification and prognosis of patients on continuous ambulatory peritoneal dialysis." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Gen S" 1 => "Inoue T" 2 => "Nodaira Y" 3 => "Ikeda N" 4 => "Kobayashi K" 5 => "Watanabe Y" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Adv Perit Dial. " "fecha" => "2008" "volumen" => "24" "paginaInicial" => "60" "paginaFinal" => "4" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18986003" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med. 2005;165:327-32. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15710797" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Wang AY" 1 => "Ho SS" 2 => "Wang M" 3 => "Liu EK" 4 => "Ho S" 5 => "Li PK" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archinte.165.3.327" "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med. " "fecha" => "2005" "volumen" => "165" "paginaInicial" => "327" "paginaFinal" => "32" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15710797" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Evaluation of cardiovascular risk factors and bone mineral density in patients undergoing coronary angiography and relation of findings to mitral annular calcium. Am J Cardiol. 2007;99:159-62. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17223411" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Evaluation of cardiovascular risk factors and bone mineral density in patients undergoing coronary angiography and relation of findings to mitral annular calcium." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Yetkin E" 1 => "Yagmur C" 2 => "Yagmur J" 3 => "Tekin GO" 4 => "Kekilli E" 5 => "Uckan A" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2006.07.077" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol. " "fecha" => "2007" "volumen" => "99" "paginaInicial" => "159" "paginaFinal" => "62" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17223411" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study. Am J Kidney Dis. 2013;61:254-61. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23122492" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Takahashi H" 1 => "Ishii H" 2 => "Aoyama T" 3 => "Kamoi D" 4 => "Kasuga H" 5 => "Ito Y" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2012.09.007" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis. " "fecha" => "2013" "volumen" => "61" "paginaInicial" => "254" "paginaFinal" => "61" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23122492" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Valvular calcification, inflammation, and mortality in dialysis patients. J Heart Valve Dis. 2013;22:584-90. <a href="http://www.ncbi.nlm.nih.gov/pubmed/24224425" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Valvular calcification, inflammation, and mortality in dialysis patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Mohamed BA" 1 => "Yang W" 2 => "Litt H" 3 => "Rosas SE." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Heart Valve Dis. " "fecha" => "2013" "volumen" => "22" "paginaInicial" => "584" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24224425" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998;13:2037-40. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9719161" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Ribeiro S" 1 => "Ramos A" 2 => "Brandão A" 3 => "Rebelo JR" 4 => "Guerra A" 5 => "Resina C" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant. " "fecha" => "1998" "volumen" => "13" "paginaInicial" => "2037" "paginaFinal" => "40" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9719161" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Heart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its prevention. Kidney Int Suppl. 2003;(85):S115-8. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Heart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its prevention." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Rufino M" 1 => "García S" 2 => "Jiménez A" 3 => "Alvarez A" 4 => "Miquel R" 5 => "Delgado P" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Kidney Int Suppl. " "fecha" => "2003" "paginaInicial" => "S115" "paginaFinal" => "8" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Vascular calcification in the uremic patient: a cardiovascular risk? Kidney Int Suppl. 2003;(85):S119-S121. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Vascular calcification in the uremic patient: a cardiovascular risk? Kidney Int Suppl." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Salgueira M" 1 => "del Toro N" 2 => "Moreno-Alba R" 3 => "Jiménez E" 4 => "Aresté N" 5 => "Palma A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "fecha" => "2003" "paginaInicial" => "S119" "paginaFinal" => "S121" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Vitamin D and vascular calcification in chronic kidney disease. Kidney Blood Press Res. 2011;34:261-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21691129" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Vitamin D and vascular calcification in chronic kidney disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Rodriguez M" 1 => "Martínez-Moreno JM" 2 => "Rodríguez-Ortiz ME" 3 => "Muñoz-Castañeda JR" 4 => "Almaden Y." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000326903" "Revista" => array:6 [ "tituloSerie" => "Kidney Blood Press Res. " "fecha" => "2011" "volumen" => "34" "paginaInicial" => "261" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21691129" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol. 2013;24:179-89. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23138485" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Mechanistic insights into vascular calcification in CKD." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Shroff R" 1 => "Long DA" 2 => "Shanahan C." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2011121191" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol. " "fecha" => "2013" "volumen" => "24" "paginaInicial" => "179" "paginaFinal" => "89" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23138485" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J. 2000;31:1975-84. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20601388" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Hjortnaes J" 1 => "Butcher J" 2 => "Figuereido JL" 3 => "Riccio M" 4 => "Kohler RH" 5 => "Kozloff KM" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehq237" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J. " "fecha" => "2000" "volumen" => "31" "paginaInicial" => "1975" "paginaFinal" => "84" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20601388" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Gender paradox in cardiac calcium deposits in middle-aged and elderly patients: mitral annular and coronary calcifications interrelationship. Maturitas Eur Menopause J. 2000;36:35-42. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Gender paradox in cardiac calcium deposits in middle-aged and elderly patients: mitral annular and coronary calcifications interrelationship." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Tenenbaum AQ" 1 => "Fishman EZ" 2 => "Pines A" 3 => "Shemesh J" 4 => "Saphira I" 5 => "Adler Y" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Maturitas Eur Menopause J. " "fecha" => "2000" "volumen" => "36" "paginaInicial" => "35" "paginaFinal" => "42" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26:1327-39. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21148030" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Raggi P" 1 => "Chertow GM" 2 => "Ureña Torres P" 3 => "Csiky B" 4 => "Agostino A" 5 => "Nossuli K" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfq725" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant. " "fecha" => "2011" "volumen" => "26" "paginaInicial" => "1327" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21148030" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Assotiation between cardiac valvular calcification and myocardial ischemia in asymptomatic high-risk patients with end-stage renal disease. Atherosclerosis. 2013;(229):369-73. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Assotiation between cardiac valvular calcification and myocardial ischemia in asymptomatic high-risk patients with end-stage renal disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Choi MJ" 1 => "Kim JK" 2 => "Kim SG" 3 => "Kim SE" 4 => "Kim SJ" 5 => "Kim HJ" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.atherosclerosis.2013.11.042" "Revista" => array:5 [ "tituloSerie" => "Atherosclerosis. " "fecha" => "2013" "paginaInicial" => "369" "paginaFinal" => "73" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24468150" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Incidencia del infarto agudo de miocardio en la evolución de los pacientes en tratamiento con diálisis. Nefrología. 2012;32:597-604. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23013945" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Incidencia del infarto agudo de miocardio en la evolución de los pacientes en tratamiento con diálisis." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Sánchez-Perales C" 1 => "Vázquez-Ruiz de Castroviejo E" 2 => "Segura-Torres P" 3 => "Borrego-Utiel F" 4 => "García-Cortés MJ" 5 => "García-García F" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3265/Nefrologia.pre2012.Jun.11464" "Revista" => array:6 [ "tituloSerie" => "Nefrología. " "fecha" => "2012" "volumen" => "32" "paginaInicial" => "597" "paginaFinal" => "604" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23013945" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Atrial fibrillation in incident dialysis patients. Kidney Int. 2009;76:324-30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19494800" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Atrial fibrillation in incident dialysis patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Vázquez E" 1 => "Sánchez-Perales C" 2 => "García-García F" 3 => "Castellano P" 4 => "García-Cortes MJ" 5 => "Liebana A" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ki.2009.185" "Revista" => array:6 [ "tituloSerie" => "Kidney Int. " "fecha" => "2009" "volumen" => "76" "paginaInicial" => "324" "paginaFinal" => "30" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19494800" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ischaemic stroke in incident dialysis patients. Nephrol Dial Transplant. 2010;25:3343-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20466665" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Ischaemic stroke in incident dialysis patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Sánchez-Perales C" 1 => "Vázquez E" 2 => "García-Cortés MJ" 3 => "Borrego J" 4 => "Polaina M" 5 => "Gutiérrez CP" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfq220" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant. " "fecha" => "2010" "volumen" => "25" "paginaInicial" => "3343" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20466665" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Sudden death in incident dialysis patients. Am J Nephrol. 2014;39:331-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/24751807" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Sudden death in incident dialysis patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Vázquez E" 1 => "Sánchez-Perales C" 2 => "García-García F" 3 => "García-Cortés MJ" 4 => "Torres J" 5 => "Borrego F" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000360547" "Revista" => array:6 [ "tituloSerie" => "Am J Nephrol. " "fecha" => "2014" "volumen" => "39" "paginaInicial" => "331" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24751807" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003500000002/v0_201504231604/X2013251415123120/v0_201504231605/en/main.assets" "Apartado" => array:4 [ "identificador" => "38708" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Originals" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003500000002/v0_201504231604/X2013251415123120/v0_201504231605/en/498v35n02a90412312pdf001.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251415123120?idApp=UINPBA000064" ]
Original language: English
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 7 | 11 |
2024 October | 40 | 28 | 68 |
2024 September | 39 | 24 | 63 |
2024 August | 44 | 40 | 84 |
2024 July | 34 | 23 | 57 |
2024 June | 60 | 30 | 90 |
2024 May | 82 | 26 | 108 |
2024 April | 60 | 24 | 84 |
2024 March | 52 | 22 | 74 |
2024 February | 46 | 30 | 76 |
2024 January | 42 | 21 | 63 |
2023 December | 38 | 23 | 61 |
2023 November | 40 | 28 | 68 |
2023 October | 47 | 22 | 69 |
2023 September | 31 | 14 | 45 |
2023 August | 55 | 26 | 81 |
2023 July | 29 | 42 | 71 |
2023 June | 59 | 32 | 91 |
2023 May | 65 | 25 | 90 |
2023 April | 31 | 8 | 39 |
2023 March | 32 | 13 | 45 |
2023 February | 18 | 17 | 35 |
2023 January | 29 | 31 | 60 |
2022 December | 52 | 31 | 83 |
2022 November | 28 | 31 | 59 |
2022 October | 34 | 19 | 53 |
2022 September | 47 | 35 | 82 |
2022 August | 35 | 44 | 79 |
2022 July | 31 | 32 | 63 |
2022 June | 42 | 28 | 70 |
2022 May | 36 | 35 | 71 |
2022 April | 32 | 34 | 66 |
2022 March | 39 | 41 | 80 |
2022 February | 37 | 37 | 74 |
2022 January | 33 | 27 | 60 |
2021 December | 31 | 40 | 71 |
2021 November | 24 | 29 | 53 |
2021 October | 39 | 49 | 88 |
2021 September | 28 | 33 | 61 |
2021 August | 34 | 34 | 68 |
2021 July | 31 | 32 | 63 |
2021 June | 28 | 13 | 41 |
2021 May | 34 | 30 | 64 |
2021 April | 71 | 58 | 129 |
2021 March | 40 | 27 | 67 |
2021 February | 31 | 15 | 46 |
2021 January | 42 | 15 | 57 |
2020 December | 32 | 12 | 44 |
2020 November | 26 | 10 | 36 |
2020 October | 17 | 15 | 32 |
2020 September | 26 | 9 | 35 |
2020 August | 41 | 17 | 58 |
2020 July | 40 | 7 | 47 |
2020 June | 27 | 10 | 37 |
2020 May | 54 | 6 | 60 |
2020 April | 31 | 14 | 45 |
2020 March | 35 | 13 | 48 |
2020 February | 44 | 22 | 66 |
2020 January | 42 | 15 | 57 |
2019 December | 36 | 23 | 59 |
2019 November | 38 | 25 | 63 |
2019 October | 31 | 13 | 44 |
2019 September | 43 | 24 | 67 |
2019 August | 24 | 12 | 36 |
2019 July | 38 | 21 | 59 |
2019 June | 39 | 16 | 55 |
2019 May | 48 | 28 | 76 |
2019 April | 77 | 23 | 100 |
2019 March | 39 | 19 | 58 |
2019 February | 20 | 9 | 29 |
2019 January | 47 | 22 | 69 |
2018 December | 74 | 39 | 113 |
2018 November | 97 | 15 | 112 |
2018 October | 79 | 10 | 89 |
2018 September | 67 | 14 | 81 |
2018 August | 41 | 14 | 55 |
2018 July | 45 | 16 | 61 |
2018 June | 35 | 11 | 46 |
2018 May | 45 | 14 | 59 |
2018 April | 41 | 10 | 51 |
2018 March | 24 | 5 | 29 |
2018 February | 27 | 5 | 32 |
2018 January | 24 | 4 | 28 |
2017 December | 38 | 8 | 46 |
2017 November | 65 | 12 | 77 |
2017 October | 50 | 2 | 52 |
2017 September | 62 | 12 | 74 |
2017 August | 76 | 6 | 82 |
2017 July | 71 | 13 | 84 |
2017 June | 77 | 9 | 86 |
2017 May | 68 | 6 | 74 |
2017 April | 38 | 5 | 43 |
2017 March | 65 | 4 | 69 |
2017 February | 53 | 9 | 62 |
2017 January | 40 | 6 | 46 |
2016 December | 124 | 17 | 141 |
2016 November | 138 | 10 | 148 |
2016 October | 171 | 26 | 197 |
2016 September | 183 | 7 | 190 |
2016 August | 340 | 0 | 340 |
2016 July | 262 | 0 | 262 |
2016 June | 184 | 0 | 184 |
2016 May | 180 | 0 | 180 |
2016 April | 167 | 0 | 167 |
2016 March | 181 | 0 | 181 |
2016 February | 232 | 0 | 232 |
2016 January | 192 | 0 | 192 |
2015 December | 201 | 1 | 202 |
2015 November | 132 | 1 | 133 |
2015 October | 131 | 5 | 136 |
2015 September | 136 | 4 | 140 |
2015 August | 153 | 9 | 162 |
2015 July | 271 | 0 | 271 |
2015 June | 172 | 0 | 172 |
2015 May | 295 | 24 | 319 |
2015 April | 33 | 0 | 33 |